Keywords:
Interventional vascular, Liver, CT-Angiography, Shunts, Cirrhosis
Authors:
A. M. K. Abdel Aal, K. Mahmoud, S. Kim, B. Heeke, N. Ertel, S. Moawad, M. Massoud, S. Saddekni, A. Gunn; BIRMINGHAM, AL/US
DOI:
10.1594/ecr2018/C-0472
Results
The study included 113 (65.3%) males and 60 females (34.7%) with a mean age of 56.5 years (SD 10.6).
The mean Charlson Index for patients' comorbidities was 3.8 (SD 1.0).
Mean MELD score increased significantly from 12.1 to 15.5 (p<0.0001) ( Table 1 ).
Re-bleeding rate after successful TIPS at 3,
6,
and 12 months was 3.96%,
11.95%,
and 12.94% respectively ( Table 2 ).
Before TIPS,
hepatic encephalopathy (HE) was documented in 11.2% of the patients.
At 3,
6,
and 12 months after TIPS,
HE was seen in 29.2%,
33.3%,
and 41.9% of patients ( Table 3 ).
TIPS revisions were performed in 2.9%,
6.4% and 6.9% of the patients at 3,
6 and 12 months following TIPS,
respectively.
Overall survival at 3,
6,
12 and 60 months was 80.9% 80.1%,
74.2% and 51.6% respectively ( Table 4 ) and ( Fig. 4 ).
Table 1: Demographics Information of our TIPS Patients with Variceal Bleeding.
Table 2: Rebleeding Rates of our TIPS patients with Variceal Hemorrhage at 3, 6, and 12 months
Table 3: Hepatic Encephalopathy Rates in our TIPS patients with Variceal Bleeding
Table 4: Overall Survival Rates in our TIPS patients with Variceal Bleeding